# APOL1 Genetic Testing in African Americans

> **NCT05656261** · — · RECRUITING · sponsor: **St. Louis University** · enrollment: 600 (estimated)

## Conditions studied

- Genetic Predisposition
- Chronic Kidney Diseases
- Nephropathy
- APOL1 Associated Kidney Disease
- Disparities

## Interventions

- **GENETIC:** Assessment of the frequency of APOL-1 renal risk variant in the black population, and evaluating their attitudes about genetic testing and APOL1 genotype via self-administered surveys

## Key facts

- **NCT ID:** NCT05656261
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-24
- **Primary completion:** 2026-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05656261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05656261, "APOL1 Genetic Testing in African Americans". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05656261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*